Kent and Medway
Joint Medicines Formulary

KMICB - Methotrexate (shared care guidance)

There is currently no commissioned mechanism for cytotoxic waste disposal in Medway. As such, GP practices providing services to patients living within Medway will not be expected to undertake shared care for cytotoxic injectables such as subcutaneous methotrexate and these medicines will remain hospital-only (RED) in this locality.

KMICB Methotrexate oral and subcutaneous for patients in adult services excluding cancer care June 2025 V1

KMICB Methotrexate Shared Care Request Letter

KMICB Methotrexate Shared Care Agreement Letter

KMICB Methotrexate Shared Care Refusal Letter

  • On Formulary Preferred
  • On Formulary Second Line
  • On Formulary Third Line
  • Specialist Initiation
  • Secondary Care Only
  • Not Approved for Formulary